| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Century Therapeutics (NASDAQ:IPSC) reported its Q4 earnings results on Thursday, March 14, 2024 at 07:30 AM.
Here's what investors need to know about the announcement.
Century Therapeutics missed estimated earnings by -18.0%, reporting an EPS of $-0.65 versus an estimate of $-0.55.
Revenue was down $253 thousand from the same period last year.
Last quarter the company missed on EPS by $0.04 which was followed by a 7.000000000000001% drop in the share price the next day.
Here's a look at Century Therapeutics's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.51 | -0.54 | -0.52 | -0.59 |
| EPS Actual | -0.55 | -0.56 | -0.53 | -0.55 |
| Revenue Estimate | 1.16M | 1.14M | 1.31M | 1.97M |
| Revenue Actual | 148K | 99K | 1.72M | 521K |
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Century Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: IPSC
